ORKA Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. (ORKA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 95% planned / 5% discretionary
Largest single sale: $1.6M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Quinlan Paul T 4 fills | General Counsel | Sell 10b5-1 | 10,000 | $93.64 | $936.4K | 37,095 −21.2% of holding | |
| Agarwal Arjun | Senior Vice President, Finance | Sell 10b5-1 | 533 | $95.75 | $51.0K | 14,219 −3.6% of holding | |
| Goncalves Joana 4 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $91.93 | $643.5K | 37,334 −15.8% of holding | |
| Klein Lawrence Otto | Chief Executive Officer | Sell | 2,452 | $95.71 | $234.7K | 923,128 −0.3% of holding | |
| Quinlan Paul T | General Counsel | Sell | 1,039 | $95.71 | $99.4K | 29,995 −3.3% of holding | |
| Goncalves Joana | Chief Medical Officer | Sell | 947 | $95.71 | $90.6K | 31,771 −2.9% of holding | |
| Sandler Laura Lee | Chief Operating Officer | Sell | 906 | $95.71 | $86.7K | 235,478 −0.4% of holding | |
| Agarwal Arjun | Senior Vice President, Finance | Sell | 560 | $95.71 | $53.6K | 14,752 −3.7% of holding | |
| Agarwal Arjun 4 fills | Senior Vice President, Finance | Sell 10b5-1 | 9,459 | $92.23 | $872.4K | 21,771 −30.3% of holding | |
| Goncalves Joana 4 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $111.84 | $782.9K | 38,818 −15.3% of holding | |
| Quinlan Paul T 6 fills | General Counsel | Sell 10b5-1 | 52,000 | $108.49 | $5.6M | 79,404 −39.6% of holding | |
| Agarwal Arjun 5 fills | Senior Vice President, Finance | Sell 10b5-1 | 10,000 | $106.66 | $1.1M | 23,212 −30.1% of holding | |
| Goncalves Joana 4 fills | Chief Medical Officer | Sell 10b5-1 | 7,000 | $86.28 | $603.9K | 39,318 −15.1% of holding | |
| Agarwal Arjun 4 fills | Senior Vice President, Finance | Sell 10b5-1 | 9,999 | $84.63 | $846.2K | 25,011 −28.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.